Skip to main content

Onychomycosis of Toenail

1
Pipeline Programs
4
Companies
4
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Hallux
HalluxCA - Laguna Hills
1 program
1
Hallux Terbinafine Subungual GelPhase 21 trial
Active Trials
NCT05135910Unknown35Est. Sep 2024
Next Science
Next ScienceAustralia - Sydney
1 program
Next Science Treatment GelN/A1 trial
Active Trials
NCT04042857Recruiting20Est. Oct 2021
Innovation Pharmaceuticals
1 program
URGO MICKAEL FilmogelN/A1 trial
Active Trials
NCT07828184Recruiting54Est. Jun 2027
Vanda Pharmaceuticals
Vanda PharmaceuticalsWASHINGTON, DC
1 program
Trichostatin APHASE_21 trial
Active Trials
NCT07065773Active Not Recruiting50Est. Sep 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Vanda PharmaceuticalsTrichostatin A
HalluxHallux Terbinafine Subungual Gel
Innovation PharmaceuticalsURGO MICKAEL Filmogel
Next ScienceNext Science Treatment Gel

Clinical Trials (4)

Total enrollment: 159 patients across 4 trials

NCT07065773Vanda PharmaceuticalsTrichostatin A

Safety, Tolerability and Efficacy of Trichostatin A in Patients With Mild to Severe Onychomycosis

Start: May 2025Est. completion: Sep 202650 patients
Phase 2Active Not Recruiting
NCT05135910HalluxHallux Terbinafine Subungual Gel

To Evaluate Hallux Terbinafine Subungual Gel (HSG) in the Treatment of Onychomycosis

Start: Jan 2022Est. completion: Sep 202435 patients
Phase 2Unknown
NCT07828184Innovation PharmaceuticalsURGO MICKAEL Filmogel

URGO MICKAEL Filmogel, Topical Treatment of Onychomycosis

Start: Jan 2026Est. completion: Jun 202754 patients
N/ARecruiting
NCT04042857Next ScienceNext Science Treatment Gel

Safety and Efficacy of Next Science Gel on Toenail Fungus

Start: Jul 2019Est. completion: Oct 202120 patients
N/ARecruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 actively recruiting trials targeting 159 patients
4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.